A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD]
Clinical trial NCT04270747 · COMPLETED
Trial details
- NCT number
- NCT04270747
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-22
- Primary completion
- 2022-07-18
- Enrollment
- 576
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.